DACI 500 MG VIAL

As referenced on , , and , Daci 500mg Vial offers a crucial therapeutic option in oncology. This powerful prescription-only medication, containing Dactinomycin, is specifically formulated for intravenous administration to combat various forms of cancer. Dactinomycin is an antineoplastic agent that works by inhibiting cell growth, making it an essential component in targeted chemotherapy regimens.

Benefits of Use:

• Targets rapidly dividing cancer cells, aiding in tumor growth reduction and control.
• Effective in treating a range of malignancies, including Wilms' tumor, rhabdomyosarcoma, Ewing's sarcoma, choriocarcinoma, and specific types of testicular cancer.
• Administered intravenously by trained healthcare professionals, ensuring precise dosage and vigilant patient monitoring.
• A vital component in multi-drug chemotherapy protocols to achieve optimal therapeutic outcomes.

How to Use:

1. Daci 500mg Vial is intended for intravenous administration only and must be prepared and given by a qualified healthcare professional.
2. Dosage and frequency of administration are highly individualized, determined by the oncologist based on the patient's specific cancer type, stage, body surface area, and overall health condition.
3. Patients will undergo regular clinical assessments and laboratory tests to monitor treatment effectiveness and manage potential side effects.
4. Do not attempt to self-administer this medication. It requires specialized handling and administration techniques.

Warnings and Precautions:

• Bone marrow suppression is a common and serious side effect, leading to reduced blood cell counts. Regular complete blood counts are essential.
• Risk of liver and kidney toxicity; liver and kidney function tests should be monitored throughout treatment.
• Can cause mucositis (inflammation of mucous membranes), stomatitis, and gastrointestinal disturbances.
• Hair loss is a frequent side effect, usually reversible upon discontinuation of treatment.
• Extravasation (leakage of medication outside the vein) can cause severe tissue damage. Administration must be carefully monitored.
• Dactinomycin is teratogenic and embryotoxic; effective contraception is required for both male and female patients during and after treatment.
• May cause immunosuppression, increasing the risk of infection.
• This medication requires strict medical supervision and is contraindicated in certain conditions. Always consult a healthcare provider for complete information.

Ingredients:

• Active Ingredient: Dactinomycin 500mg
• Inactive Ingredients: Typically mannitol and other excipients suitable for injection, but specific inactive ingredients may vary by manufacturer and are not detailed here.

Product Details:

• Brand: Daci
• Strength: 500mg
• Form: Vial for Injection
• Administration Method: Intravenous
• Drug Type: Prescription Only Medicine (POM)
• Active Substance: Dactinomycin
• Gender: Unisex